Home  |  繁體  |  簡体
  Bloomage BioTechnology Corporation Limited was incorporated in Caymans Island on 3 April 2006. It holds 100% equity interest of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – which were both incorporated in the British Virgin Islands. ...more  

Annual Report


Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2017


Announcements and Notices - Notice of Annual General Meeting


Circulars - Renewal of General Mandates to Issue New Shares and Buy-back Shares, Declaration of Final Dividend, Retirement of Directors and Re-election of Retiring Directors and Notice of Annual General Meeting

HA End Products - Medical device products
The injectable hyaluronan soft tisse filling gel (Trademark: BioHyalux) is the end product the Group launched in the market in 2012. Also, we have reserved products known as the medical use sodium hyaluronate gel (Trademark: HYMOIS) and the intra-articular injection (Trademark: Hyprojoint) and so forth.
To learn more……
HA Raw Materials
The HA Materials are produced by microbial fermentation, using non-genetically modified strains from non-animal sources. The products are safe, pure and stable.
To learn more……
Links to related companies
Bloomage Freda Biopharm Co., Ltd
Beijing Bloomage Hyinc Technology Co., Ltd